In a study by Russo et al., comparing gut peptide levels between 42 PDS and 12 EPS patients, somatostatin levels tended to be lower in PDS compared to EPS but this did not reach statistical significance ( 34 ).
← all excerpts
The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review.
2
—
—
The sentences
showed a trend toward higher somatostatin and motilin levels in EPS patients compared to PDS patients ( 32 ).